About: Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.99 (-6.78%)
ACET NASDAQ Adicet Bio Inc
Adicet Bio Inc share price
ACET price activity
Last Price
$4.040
Change (24hr)
-0.24 USD (5.61%)
Volume
162.44K
Volume (4w avg)
-
Open
$4.22
Day Range
$3.97 - $4.29
Previous Close
$4.28
Last Trade
23 Oct, 8:07 pm GMT+0
Delayed
23 Oct, 8:07 pm GMT+0
ACET price performance
Delayed
23 Oct, 8:07 pm GMT+0
ACET Market Signals